VDVehbi Doğan

Vehbi Doğan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vehbi Doğan has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical outcomes of injectable and conventional pulmonary valve replacement in severe pulmonary regurgitation

    by Sercan Tak, Murat Koç, Ali̇ Kutsal, Vehbi̇ Doğan

    Background/aim: Pulmonary regurgitation following tetralogy of Fallot repair is a common long-term complication requiring pulmonary valve replacement. Injectable bioprosthetic valves offer a less invasive alternative to conventional surgical replacement, but comparative data in pediatric populations remain limited. This study aimed to evaluate short-term and long-term clinical outcomes of injectable pulmonary valve replacement and conventional pulmonary valve replacement in pediatric patients with severe pulmonary regurgitation following tetralogy of Fallot repair. Materials and methods: This retrospective study included 22 pediatric patients who underwent pulmonary valve replacement. Patients were divided into injectable (n = 9) and conventional (n = 13) groups based on anatomical criteria. Primary outcomes included early postoperative parameters and long-term valve function. The mean follow-up duration was 10.5 ± 2.5 years. Results: Favorable early outcomes were noted in the injectable pulmonary valve replacement cohort, including shorter intensive care unit stay (16.8 ± 6.2 vs. 37.0 ± 23.4 h, p = 0.021), reduced mechanical ventilation duration (5.2 ± 3.9 vs. 15.4 ± 11.4 h, p = 0.019), decreased chest tube drainage (206.7 ± 108.2 vs. 513.1 ± 274.1 mL, p = 0.005), and shorter hospital stay (5.4 ± 2.4 vs. 8.4 ± 3.1 days, p = 0.026). Long-term outcomes indicated similar valve function and right ventricular remodeling in the two groups, with excellent freedom from reintervention (100%) during follow-up. Conclusion: Injectable pulmonary valve replacement appears to be a safe alternative, offering favorable early outcomes and long-term valve performance comparable to conventional methods. However, clinical experience and precise patient selection remain critical for achieving optimal results.

  • Open Access

    Assessment of cardiac involvement in childhood neurofibromatosis type 1 diagnoses, identification of Rasopathic Cases

    by İlYas Emre Tekdemir, Hülya Kayılıoğlu, Vehbi Doğan, Ayşe Aksoy, Ülkühan Öztoprak, Erhan Aksoy, Çiğdem Genç Sel, Deniz Yüksel

    This study aimed to investigate cardiac involvement in children and adolescents with neurofibromatosis type 1 (NF1), and to describe clinical correlates. Medical records of 114 NF1 patients (ages 1-18 years) followed at a tertiary center (2011–2017) were retrospectively reviewed. Among these patients, 58 (50.9%) underwent pediatric cardiology assessment with echocardiography (ECHO) and electrocardiography (ECG). ECHO abnormalities were defined a priori (valvular disease, septal hypertrophy, septal defects, and pulmonary valve stenosis); patent foramen ovale (PFO) was considered a normal variant. Demographics and NF1 features were compared between patients with and without cardiac pathology. Among the 58 evaluated patients, ECHO was abnormal in 18/58 (31.0%; 95% CI 20.6–43.8) and 1/58 (1.7%; 95% CI 0.3–9.1) had isolated ventricular extrasystoles, yielding 19/58 (32.8%; 95% CI 22.1–45.6) with any cardiac pathology. Valvular involvement occurred in 13/58 (22.4%; 95% CI 13.6–34.7); septal hypertrophy and septal defects each in 3/58 (5.2%; 95% CI 1.8–14.1); pulmonary valve stenosis in 1/58 (1.7%; 95% CI 0.3–9.1). No statistically significant difference in age, sex, or NF1 diagnostic features was observed between those with vs. without cardiac pathology (all p>0.05). Cardiac pathology was common among NF1 patients referred for cardiology evaluation, with valvular disease predominating. Given retrospective design and potential referral/selection bias, a routine baseline cardiology assessment at NF1 diagnosis appears reasonable, with a low threshold for follow‑up when symptoms, murmurs, or risk factors are present.

  • Open Access

    Recurrent pericarditis in children: Clinical findings and outcomes

    by İlknur Bağrul, Elif Arslanoğlu Aydın, Esra Bağlan, Vehbi Doğan, Utku Arman Örün, Semanur Elmas

    Objective: In this study, we aimed to evaluate the clinical findings and follow-up data of children with recurrent pericarditis (RP). Material and Methods: This study had a retrospective design and included pediatric patients with recurrent pericarditis evaluated between January 2017 to January 2023. The initial diagnosis of pericarditis was made according to the criteria determined in the European Society of Cardiology guideline. Results: We enrolled 16 children (14 males) with recurrent pericarditis with median age 12.8 (8 – 17) years. Eight patients (50%) presented with fever, pericardial effusion in 11 patients (68.7%). Pericardiocentesis was performed in 9 (56.2%) patients. The median erythrocyte sedimentation rate (ESR); C-reactive protein (CRP) levels at the time of diagnosis were 43 (25-70) mm/h and 107 (61-190) mg/dl, respectively. In total, 16 patients had 36 recurrences during follow-up. The main symptom during the relapses was chest pain, similar to that of the first attack. Four patients (25%) had a history of previous cardiac surgery. Three patients were treated with nonsteroidal anti-inflammatory drugs (NSAIDs) only. NSAID and colchicine were administered to 13 patients. One patient received corticosteroid and one patient received anakinra treatment. Conclusion: Patients with recurrent pericarditis in childhood have an autoinflammatory phenotype. Furthermore, successful management of patients with recurrent pericarditis requires a teamwork approach involving cardiologists, rheumatologists and clinical immunologists.

  • Open Access

    The impact of vasoactive inotropic score values on mortality and ECMO-related complications in children

    by Murat Koç, Sercan Tak, Vehbi Doğan, Ali Kutsal

    The impact of vasoactive inotropic score values on mortality and ECMO-related complications in children - Turkish Journal of Thoracic and Cardiovascular Surgery

  • Pediatric Choreiform Movement Disorders: A Retrospective Analysis

    by Hülya Kayılıoğlu, Deniz Yüksel, Ayşe Aksoy, Mehpare Özkan, Ülkühan Öztoprak, Çiğdem Genç Sel, Vehbi Doğan

    Objective: Chorea is a rare hyperkinetic movement disorder in children, characterized by involuntary, irregular, and rapid movements. Sydenham’s chorea (SC), an autoimmune complication of rheumatic fever, is the most common cause of chorea in pediatric populations. This study aims to retrospectively evaluate the clinical features, neuroimaging findings, treatment responses, and prognostic factors in children with choreiform movement disorders, with a focus on relapse rates and treatment efficacy.Materials and Methods: We conducted a retrospective review of pediatric patients diagnosed with choreiform movement disorders at Dr. Sami Ulus Children's Hospital between 2010 and 2018. Demographic data, clinical presentation, neuroimaging findings, treatments, and relapse outcomes were analyzed.Results: Of the 74 patients, 94.6% had secondary chorea, with 91.9% diagnosed with SC. The mean age at diagnosis was 133.5 ± 33.9 months, with 71.2% female. Brain magnetic resonance imaging findings were normal in 71.4% of the patients who underwent it. Haloperidol was the most commonly used treatment, with 87.3% of SC patients showing a positive response. Relapse occurred in 11.6% of patients, with no significant differences in symptom duration, treatment duration, or age at diagnosis between those with and without relapse (p > 0.05). The median time to relapse was 21 months.Conclusion: SC is the most common cause of chorea in children, and haloperidol is an effective first-line treatment. However, relapses remain a concern, highlighting the need for long-term follow-up. No significant differences were found in clinical parameters between relapsing and non-relapsing patients. Further research is needed to identify relapse predictors.

  • Congenital aneurysm of the ductus arteriosus in neonates; should we be afraid?

    by V. Doğan, İU Sayıcı, B. Kaya, Ön Aksoy, K. Sel

    Background: Although isolated ductus arteriosus aneurysm has been reported as 0.8% in autopsy series, it has recently been reported as up to 8.8% with increased awareness. Most cases are asymptomatic and regress spontaneously. In this study, we aimed to evaluate the characteristics, clinical manifestations, and outcomes of ductus arteriosus aneurysm in neonates. Material and Methods: A total of 22 newborns with echocardiographic images recorded in the hospital registry system were identified to have a ductus arteriosus aneurysm. The demographic, clinical, and echocardiographic findings of the patients were extracted from the hospital records. Results: The mean gestational age and weight at birth of the newborns were 38 6/7 weeks (35 3/7 – 40 6/7 weeks) and 3203 g (2445–4080 g), respectively. The maximal length and width of the aneurysm ranged from 6 to 21 mm and 5.3 to 13 mm, respectively. In three of the patients, thrombus in the aneurysm was detected on the third day of life, leading to surgical excision of thrombus and ligation of the aneurysm in two. In the remaining 19 patients, the aneurysm regressed spontaneously and closed in an average of 5.3 days. Conclusion: With increased awareness and earlier and more frequent application of echocardiography in newborns, the diagnosis of ductus arteriosus aneurysm is being reported more frequently. The most common scenario is spontaneous regression, however, it should not be forgotten that it can lead to serious complications, as reported previously. In selected cases, surgical treatment may be an option to prevent more serious or late complications, though the indications for surgical intervention remain unclear.

  • Open Access

    Outcomes of the pediatric patients undergoing pericardiocentesis for cardiac surgery-related massive pericardial effusion

    by Vehbi Doğan, Furkan Donbaloğlu, İlker Ufuk Sayıcı, Murat Koç

    Aims: In this study, we aimed to evaluate the demographic and clinical characteristics of the patients who have moderate or severe cardiac surgery related pericardial effusion and relieved by pericardiocentesis. Methods: Twenty-one children (0-18 years of age) were identified retrospectively in a 10-year period (2010-2020) and we reviewed our medical records for demographic and clinical characteristics, management strategies and outcome of the patients. Results: Twenty-one patients were identified with a male to female ratio of 1.1. Mean age and body weight of the patients were 79.7 ± 56.6 months and 19.5 ± 14 kg respectively. Of the patients (33%) had at least one complaint, most common being dyspnea (19%) and fatigue (8.5%). The mean period between heart surgery and pericardiocentesis was 30.1±13.4 days. The distribution of surgical indications was as follows; atrial septal defect (42.8%), ventricular septal defect (23.8%), endocardial cushion defect (9.5%). The mean largest diameter of effusion and amount of fluid drained were 34.9 ± 13.4 mm and 349.3 ± 276.1 ml respectively. Macroscopic appearance of the fluid was serous in 28.5%, hemorrhagic in 66.7% and chylous in 4.8% patient. Of the 21 patients 13 were treated with anti-inflammatory drugs; NSAID (14.8%), NSAID and colcihicine (33.3%) NSAID, colchicine and coticosteroid (14.8%). On the follow up 2 (9.5%) patient died because of sepsis and heart failure. There were no procedure related complication, chronic effusion or constriction on the follow up. Conclusion: In conclusion, PPS is an important clinical syndrome that can lead to serious consequences. Therefore, patients at risk should be identified in the postoperative period and a patient-specific follow-up plan should be made. In the presence of tamponade or serious effusion, pericardiocentesis is a safe, effective and life-saving procedure in patients unresponsive to medical treatment along with anti-inflammatory drugs.

  • Aetiological distribution and clinical features in children with large pericardial effusion who underwent pericardiocentesis

    by Furkan Donbaloğlu, Vehbi Doğan, Serpil Kaya Çelebi, Meryem Beyazal, İlker U. Sayıcı, Zeynep Donbaloğlu

    Background: We aimed to evaluate the clinical and laboratory characteristics and aetiological factors of patients who underwent pericardiocentesis for moderate to large pericardial effusion.Method: A total of 38 patients who underwent pericardiocentesis due to moderate-severe pericardial effusion and not related to cardiac surgery were included in the study.Results: The male-to-female ratio was 2.16, and found to be 7.5 in patients over 3 years of age. Mean age and body weight of the patients were 69.4 ± 74.9 months and 22.5 ± 22.4 kg. Dyspnoea (51.7%) was the most common complaint, followed by chest pain (37.9%). Tamponade was present in 23.7% of the patients. The largest diameter of effusion was 24.4 ± 10.4 mm. The amount of fluid drained was 279.24 ± 279 ml. Macroscopic appearance was serous in 12 (34.3%), and haemorrhagic in 18 (51.4%). No complication related to procedure was seen. Aetiology for efusion was infectious in 26%, idiopathic in 18%, iatrogenic in 11%, rheumatological in 11%, malignancy in 8%, cardiomyopathy in 8%, and other factors related in 18%. Of the 38 patients, 16 received nonsteroidal anti-inflammatory drugs (NSAID), and colchicine and corticostreoid were added in nine and two patients, respectively. A total of eight (21%) patients died during follow-up.Conclusion: In conclusion, percutaneous pericardiocentesis can be applied safely and the underlying aetiology is decisive in the prognosis of the patient. Although pericardial effusion in children is often due to inflammation of the pericardium, it can develop as a finding of many local or systemic diseases that should be kept in mind.


  • Isolated mitral valve aneurysm in a 9-year old boy

    by Vehbi Doğan, Kutay Sel

    Background. Isolated mitral valve aneurysm is rarely reported in children. In most cases it is associated with an underlying disease such as infective endocarditis. MVA can lead to severe complications that needs surgical intervention. Case. In this report, we present a 9-year old asymptomatic male patient with anterior mitral valve aneurysm and rhythm disturbance diagnosed incidentally during pre-operative evaluation. Conclusions. Being rare in children, isolated MVA should be kept in mind in the differential diagnosis of mass lesions seen on the atrial side of the mitral valve. A 24-hour electrocardiogram may define subtle rhythm disturbances in these patients.


  • Open Access

    Isolated mitral valve aneurysm in a 9-year old boy

    by Vehbi Dogan, Kutay Sel

    Isolated mitral valve aneurysm is rarely reported in children. In most cases it is associated with underlying diseaes such as infective endocarditis. MVA can lead to severe complications that needs surgical intervention. In this report, we present a 9-year old asymptomatic male patient with anterior mitral valve aneurysm diagnosed incidentally during pre-operative evaluation.